Robert L. Scavo - 29 Dec 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Information Officer
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert L. Scavo
Issuer symbol
ALHC
Transactions as of
29 Dec 2025
Net transactions value
-$1,303,384
Form type
4
Filing time
30 Dec 2025, 17:01:04 UTC
Previous filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scavo Robert L. Chief Information Officer 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE /s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert L. Scavo 30 Dec 2025 0001975024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale $1,229,482 -65,728 -11% $18.71 506,827 29 Dec 2025 Direct F1, F2
transaction ALHC Common Stock Sale $73,903 -3,813 -0.75% $19.38 503,014 29 Dec 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from 18.23 to $19.225. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.23 to $19.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.